サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1584127

がん医療におけるゲノミクス市場：検査タイプ別、技術タイプ別、用途別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、2024-2032年予測

Genomics in Cancer Care Market, By Test Type, By Technology Type, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 284 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
がん医療におけるゲノミクス市場：検査タイプ別、技術タイプ別、用途別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、2024-2032年予測
出版日: 2024年10月26日
発行: AnalystView Market Insights
ページ情報: 英文 284 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

がん医療におけるゲノミクス市場規模は2023年に181億2,032万米ドルとなり、2024年から2032年にかけて16.10%のCAGRで拡大

がん医療におけるゲノミクス市場-市場力学

個別化医療重視の高まりががん医療におけるゲノム市場を促進

個別化医療の重視の高まりは、がん医療におけるゲノミクス市場を大きく後押ししています。これは、ゲノム・プロファイリングに基づく個別化治療ががん症例の30%以上で患者の転帰を改善できるという米国国立がん研究所の調査結果からも明らかです。米国臨床腫瘍学会（ASCO）のような組織は、治療の意思決定におけるゲノムデータの統合を提唱し、腫瘍内の遺伝子変異を特異的に標的とする精密治療の開発を推進しています。さらに、米国国立衛生研究所によるAll of Us研究プログラムのような大規模なイニシアチブは、遺伝的要因ががんや治療効果にどのように影響するかをよりよく理解するために、多様な集団から広範なゲノムデータを収集することを目的としています。その結果、個別化医療は概念から実践へと移行しつつあり、個々の患者にとって最も効果的な治療法を特定するためにゲノム検査が臨床の場でますます採用されるようになっています。

がん医療におけるゲノミクス市場-主な洞察

弊社のリサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約16.10%のCAGRで毎年成長すると予測されています。

検査タイプ別では、生殖細胞系列ゲノム検査が2023年に最大の市場シェアを示すと予測されます。

技術タイプ別では、次世代シーケンシング（NGS）が2023年の主要タイプでした。

用途別では、個別化医療が2023年の主要タイプでした。

地域別では、北米が2023年の売上高でトップ

がん医療におけるゲノミクス市場-セグメンテーション分析：

がん医療におけるゲノミクスの世界市場は、検査タイプ、技術タイプ、用途、エンドユーザー、地域に基づいてセグメント化されます。

市場は検査タイプに基づいて2つのカテゴリーに分けられる：生殖細胞ゲノム検査と体細胞ゲノム検査です。生殖細胞系列ゲノム検査は、遺伝性がんリスクの特定と予防戦略への情報提供において重要な役割を果たすため、最高位にランクされています。体細胞ゲノミクス検査は、腫瘍特異的な変異に焦点を当て、がん治療における個別化治療の選択肢に不可欠な知見を提供するため、これに続く。

市場は技術タイプに基づいて4つのカテゴリーに分類される：次世代シーケンサー、PCR、マイクロアレイ、CRISPRです。次世代シーケンシング（NGS）は、膨大な量のゲノムデータを効率的に解析できることから、最優先されています。PCRがそれに続き、標的増幅に広く使われています。マイクロアレイ技術は第3位で、CRISPRは革新的ではあるが、臨床応用ではまだ新興です。

がん医療におけるゲノミクス市場-地理的洞察

北米は、高度な医療インフラと研究開発への多額の投資により、がん医療におけるゲノミクス市場を独占しています。米国国立がん研究所は、ゲノム検査ががん患者の50%近くを治療する指針になると報告しており、精密医療におけるゲノミクスの重要な役割が浮き彫りになっています。ドイツや英国のような国々は、500万人以上の患者の日常的ながん治療にゲノム検査を統合することを目的としたゲノム英国国民保健サービス（NHS）プロジェクトなど、強固なゲノム医療イニシアチブを実施しています。アジア太平洋地域では、中国や日本のような国々がゲノム技術を急速に導入しています。中国の第13次5ヵ年計画ではバイオテクノロジーの開発を重視しており、ゲノム研究と応用への投資を増やす計画です。ラテンアメリカではゲノム検査へのアクセスが徐々に改善されつつあり、ブラジル保健省はがん治療ガイドラインにゲノミクスを組み込む取り組みを推進しています。一方、中東・アフリカでは、ゲノム医療をサポートするヘルスケアインフラの強化に注力しており、革新的なゲノムアプローチを通じてがんに取り組む姿勢の高まりを反映しています。

がん医療におけるゲノミクス市場-競合情勢：

がん医療におけるゲノミクス市場の競合情勢は、主に北米が主導しており、イルミナやサーモフィッシャーサイエンティフィックなどの主要企業が技術革新を推進しています。2023年、IlluminaはIllumina NextSeq 2000システムを発売し、がん診断と研究のためのゲノムシーケンス機能を大幅に強化しました。欧州では、ロシュは手ごわい競争相手であり、さまざまなヘルスケア機関と積極的に協力し、ゲノム検査を臨床診療に組み込むことで、患者の転帰を改善しています。ロシュとジェノミクス・イングランド構想との提携は、10万人のがん患者のゲノムデータを解析し、個別化治療戦略への道を開くことを目的としています。一方、アジア太平洋地域では、BGIグループが、大規模ゲノム研究を促進するDNBSEQプラットフォームを開発し、顕著な進歩を遂げています。さらに、イルミナによるGrail社の買収は、診断精度を高めるためにリキッドバイオプシー技術を活用し、早期がん検出市場での地位を強化しています。この競合環境は、ゲノムの進歩を活用して世界的にがん医療に革命を起こすというコミットメントを示すものであり、共同研究やイノベーションが腫瘍学の未来を形成しています。

目次

第1章 がん医療におけるゲノミクス市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 がん医療におけるゲノミクスの主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 がん医療におけるゲノミクスの研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 がん医療におけるゲノミクス： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 がん医療におけるゲノミクスの市場情勢

  • がん医療におけるゲノミクスの市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 がん医療におけるゲノミクス-検査タイプ別

  • 概要
    • 検査タイプ別セグメントシェア分析
    • 生殖細胞ゲノム検査
    • 体細胞ゲノム検査

第8章 がん医療におけるゲノミクス-技術タイプ別

  • 概要
    • 技術タイプ別セグメントシェア分析
    • 次世代シーケンシング（NGS）
    • PCR
    • マイクロアレイ
    • クリスパー

第9章 がん医療におけるゲノミクス-用途別

  • 概要
    • 用途別セグメントシェア分析
    • バイオマーカーの発見
    • パーソナライズ医療
    • 医薬品の発見と開発
    • 臨床診断

第10章 がん医療におけるゲノミクス-エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • 病院
    • 診断検査室
    • 調査機関
    • 製薬・バイオテクノロジー企業

第11章 がん医療におけるゲノミクス-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析- がん医療におけるゲノミクス

  • 競合ダッシュボード
  • 企業プロファイル
    • Adaptive Biotechnologies Corporation
    • Agilent Technologies, Inc.
    • BGI Group
    • Bio-Rad Laboratories, Inc.
    • F. Hoffmann-La Roche AG
    • Foundation Medicine, Inc.（Roche）
    • Genomic Health, Inc.（Exact Sciences）
    • Guardant Health, Inc.
    • Illumina, Inc.
    • Myriad Genetics, Inc.
    • NeoGenomics, Inc.
    • Oxford Nanopore Technologies Ltd.
    • Pacific Biosciences of California, Inc.
    • PerkinElmer, Inc.
    • Qiagen NV
    • Thermo Fisher Scientific Inc.
    • Others

第13章 アナリストの全方位展望

目次
Product Code: ANV4110

REPORT HIGHLIGHT

Genomics in Cancer Care Market size was valued at USD 18,120.32 Million in 2023, expanding at a CAGR of 16.10% from 2024 to 2032.

The Genomics in Cancer Care Market encompasses the application of genomic technologies to enhance cancer diagnosis, treatment, and prevention strategies. With the increasing understanding of the genetic basis of cancer, there is a growing emphasis on personalized medicine, which has led to significant advancements in genomics. A report from the National Cancer Institute indicated that genomic testing could improve treatment outcomes for over 40% of cancer patients by identifying specific mutations. The rising prevalence of cancer globally, coupled with the growing demand for precision therapies, is boosting market growth. However, challenges such as high costs associated with genomic testing and a lack of standardized guidelines may restrain widespread adoption. Additionally, ethical concerns surrounding genetic data usage present barriers to market expansion. Opportunities are emerging in the development of innovative genomic technologies, such as liquid biopsies and next-generation sequencing, which are transforming cancer diagnostics and treatment approaches. These advancements are expected to enhance patient outcomes and drive the future of cancer care.

Genomics in Cancer Care Market- Market Dynamics

Growing Emphasis on Personalized Medicine Propels the Genomics in Cancer Care Market

The growing emphasis on personalized medicine is significantly propelling the Genomics in Cancer Care Market, as evidenced by the National Cancer Institute's findings that tailored treatments based on genomic profiling can improve patient outcomes in over 30% of cancer cases. Organizations like the American Society of Clinical Oncology (ASCO) advocate for the integration of genomic data in treatment decision-making, promoting the development of precision therapies that specifically target genetic mutations in tumors. Additionally, large-scale initiatives, such as the All of Us Research Program by the National Institutes of Health, aim to gather extensive genomic data from diverse populations to better understand how genetic factors influence cancer and treatment efficacy. As a result, personalized medicine is transitioning from concept to practice, with genomic tests being increasingly adopted in clinical settings to identify the most effective treatments for individual patients, ultimately leading to better management of cancer care and improved survival rates.

Genomics in Cancer Care Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 16.10% over the forecast period (2024-2032)

Based on Test Type segmentation, Germline genomics testing was predicted to show maximum market share in the year 2023

Based on Technology Type segmentation, Next-Generation Sequencing (NGS) was the leading type in 2023

Based on Application segmentation, Personalized Medicine was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Genomics in Cancer Care Market- Segmentation Analysis:

The Global Genomics in Cancer Care Market is segmented on the basis of Test Type, Technology Type, Application, End-User, and Region.

The market is divided into two categories based on Test Type: Germline Genomics Testing, and Somatic Genomics Testing. Germline genomics testing ranks highest due to its critical role in identifying hereditary cancer risks and informing prevention strategies. Somatic genomics testing follows as it focuses on tumor-specific mutations, providing essential insights for personalized treatment options in cancer care.

The market is divided into four categories based on Technology Type: Next-Generation Sequencing, PCR, Microarray, and CRISPR. Next-Generation Sequencing (NGS) holds the highest priority due to its ability to analyze vast amounts of genomic data efficiently. PCR follows, widely used for targeted amplification. Microarray technology ranks third, while CRISPR, although innovative, is still emerging in clinical applications.

Genomics in Cancer Care Market- Geographical Insights

North America dominates the Genomics in Cancer Care Market, driven by advanced healthcare infrastructure and significant investments in research and development. The U.S. National Cancer Institute reported that genomic testing could guide treatment for nearly 50% of cancer patients, highlighting its critical role in precision medicine. Europe follows closely, with countries like Germany and the UK implementing robust genomic medicine initiatives, such as the Genomic UK National Health Service (NHS) project, aiming to integrate genomic testing into routine cancer care for over 5 million patients. In the Asia-Pacific region, countries like China and Japan are rapidly adopting genomic technologies; China's 13th Five-Year Plan emphasizes the development of biotechnology, with plans to increase investment in genomic research and application. Latin America is gradually improving access to genomic testing, with Brazil's Ministry of Health promoting initiatives to incorporate genomics into cancer treatment guidelines. Meanwhile, the Middle East & Africa are focusing on enhancing healthcare infrastructure to support genomic medicine, reflecting a growing commitment to tackling cancer through innovative genomic approaches.

Genomics in Cancer Care Market- Competitive Landscape:

The competitive landscape of the Genomics in Cancer Care Market is primarily led by North America, with key players like Illumina and Thermo Fisher Scientific driving innovation. In 2023, Illumina launched its Illumina NextSeq 2000 system, which significantly enhances genomic sequencing capabilities for cancer diagnostics and research. In Europe, Roche is a formidable competitor, actively collaborating with various healthcare institutions to integrate genomic testing into clinical practices, thus improving patient outcomes. Roche's partnership with the Genomics England initiative aims to analyze genomic data from 100,000 cancer patients, paving the way for personalized treatment strategies. Meanwhile, in the Asia-Pacific region, BGI Group is making notable advancements, having developed the DNBSEQ platform to facilitate large-scale genomic studies. Additionally, the acquisition of Grail by Illumina has reinforced its position in the early cancer detection market, utilizing liquid biopsy technology to enhance diagnostic precision. This competitive environment showcases a commitment to leveraging genomic advancements to revolutionize cancer care globally, with collaborations and innovations shaping the future of oncology.

Recent Developments:

In September 2024, The Indian Cancer Genome Atlas (ICGA) recently launched a multi-omics data portal for cancer, which is the first of its kind in India. The portal provides access to data on breast cancer patients, including their DNA, RNA, and protein profiles, treatment histories, and patient outcomes. The ICGA's goal is to create datasets specific to India to help researchers and clinicians develop personalized cancer treatments.

In September 2024, The UK's first robotic genomic testing facility was launched at The Royal Marsden NHS Foundation Trust, enhancing cancer patient care. This automation will double testing capacity, streamline processes, and improve access to personalized treatments by identifying genetic risks and mutations.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GENOMICS IN CANCER CARE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Adaptive Biotechnologies Corporation
  • Agilent Technologies, Inc.
  • BGI Group
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Foundation Medicine, Inc. (Roche)
  • Genomic Health, Inc. (Exact Sciences)
  • Guardant Health, Inc.
  • Illumina, Inc.
  • Myriad Genetics, Inc.
  • NeoGenomics, Inc.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences of California, Inc.
  • PerkinElmer, Inc.
  • Qiagen N.V.
  • Thermo Fisher Scientific Inc.
  • Others

GLOBAL GENOMICS IN CANCER CARE MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Germline Genomics Testing
  • Somatic Genomics Testing

GLOBAL GENOMICS IN CANCER CARE MARKET, BY TECHNOLOGY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Next-Generation Sequencing (NGS)
  • PCR
  • Microarray
  • CRISPR

GLOBAL GENOMICS IN CANCER CARE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Biomarker Discovery
  • Personalized Medicine
  • Drug Discovery & Development
  • Clinical Diagnostics

GLOBAL GENOMICS IN CANCER CARE MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Diagnostic Laboratories
  • Research Institutes
  • Pharmaceutical & Biotechnology Companies

GLOBAL GENOMICS IN CANCER CARE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Genomics in Cancer Care Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Genomics in Cancer Care Market Snippet by Test Type
    • 2.1.2. Genomics in Cancer Care Market Snippet by Technology Type
    • 2.1.3. Genomics in Cancer Care Market Snippet by Application
    • 2.1.4. Genomics in Cancer Care Market Snippet by End-User
    • 2.1.5. Genomics in Cancer Care Market Snippet by Country
    • 2.1.6. Genomics in Cancer Care Market Snippet by Region
  • 2.2. Competitive Insights

3. Genomics in Cancer Care Key Market Trends

  • 3.1. Genomics in Cancer Care Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Genomics in Cancer Care Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Genomics in Cancer Care Market Opportunities
  • 3.4. Genomics in Cancer Care Market Future Trends

4. Genomics in Cancer Care Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Genomics in Cancer Care Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Genomics in Cancer Care Market Landscape

  • 6.1. Genomics in Cancer Care Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Genomics in Cancer Care Market - By Test Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Test Type, 2023 & 2032 (%)
    • 7.1.2. Germline Genomics Testing
    • 7.1.3. Somatic Genomics Testing

8. Genomics in Cancer Care Market - By Technology Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology Type, 2023 & 2032 (%)
    • 8.1.2. Next-Generation Sequencing (NGS)
    • 8.1.3. PCR
    • 8.1.4. Microarray
    • 8.1.5. CRISPR

9. Genomics in Cancer Care Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2. Biomarker Discovery
    • 9.1.3. Personalized Medicine
    • 9.1.4. Drug Discovery & Development
    • 9.1.5. Clinical Diagnostics

10. Genomics in Cancer Care Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Diagnostic Laboratories
    • 10.1.4. Research Institutes
    • 10.1.5. Pharmaceutical & Biotechnology Companies

11. Genomics in Cancer Care Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Genomics in Cancer Care Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Genomics in Cancer Care Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Genomics in Cancer Care Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Genomics in Cancer Care Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Genomics in Cancer Care Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Genomics in Cancer Care Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Adaptive Biotechnologies Corporation
    • 12.2.2. Agilent Technologies, Inc.
    • 12.2.3. BGI Group
    • 12.2.4. Bio-Rad Laboratories, Inc.
    • 12.2.5. F. Hoffmann-La Roche AG
    • 12.2.6. Foundation Medicine, Inc. (Roche)
    • 12.2.7. Genomic Health, Inc. (Exact Sciences)
    • 12.2.8. Guardant Health, Inc.
    • 12.2.9. Illumina, Inc.
    • 12.2.10. Myriad Genetics, Inc.
    • 12.2.11. NeoGenomics, Inc.
    • 12.2.12. Oxford Nanopore Technologies Ltd.
    • 12.2.13. Pacific Biosciences of California, Inc.
    • 12.2.14. PerkinElmer, Inc.
    • 12.2.15. Qiagen N.V.
    • 12.2.16. Thermo Fisher Scientific Inc.
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us